Cougar Biotechnology, Inc. clinical trials
Acquired by Johnson & Johnson, 2009 · source ↗
The registry lists 12 studies whose lead sponsor is Cougar Biotechnology, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 21, 2018.
Before and after it joined Johnson & Johnson
- First submitted before Cougar Biotechnology, Inc. became part of Johnson & Johnson
- 5
- First submitted after Cougar Biotechnology, Inc. became part of Johnson & Johnson
- 6
- Unclear, or no submission date
- 1
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Cougar Biotechnology, Inc.12 studies
Something wrong with this grouping? Tell us on the Johnson & Johnson page.
Studies
Recruiting first, then most recently updated. Showing 12 of 12. All Johnson & Johnson studies →
- A Safety Study of Abiraterone Acetate Administered in Combination With Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)CompletedNCT01400555Phase 1
Sponsor listed in the registry: Cougar Biotechnology, Inc. · First submitted after Cougar Biotechnology, Inc. became part of Johnson & Johnson
- A Study of Noscapine HCl (CB3304 ) in Patients With Relapsed or Refractory Multiple MyelomaTerminatedNCT00912899Phase 1
Sponsor listed in the registry: Cougar Biotechnology, Inc. · Unclear whether first submitted before or after Cougar Biotechnology, Inc. became part of Johnson & Johnson
- Neo-adjuvant Abiraterone + Luteinizing Hormone-Releasing Hormone (LHRH) Versus LHRH in Prostate CancerCompletedNCT01088529Phase 2
Sponsor listed in the registry: Cougar Biotechnology, Inc. · First submitted after Cougar Biotechnology, Inc. became part of Johnson & Johnson
- An Safety and Efficacy Study of Abiraterone Acetate in Participants With Advanced Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based ChemotherapyCompletedNCT00474383Phase 2
Sponsor listed in the registry: Cougar Biotechnology, Inc. · First submitted before Cougar Biotechnology, Inc. became part of Johnson & Johnson
- Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based ChemotherapyCompletedNCT00638690Phase 3
Sponsor listed in the registry: Cougar Biotechnology, Inc. · First submitted before Cougar Biotechnology, Inc. became part of Johnson & Johnson
- A Safety and Efficacy Study of Abiraterone Acetate in Participants With Prostate Cancer Who Have Failed Hormone TherapyCompletedNCT00473512Phase 1/2
Sponsor listed in the registry: Cougar Biotechnology, Inc. · First submitted before Cougar Biotechnology, Inc. became part of Johnson & Johnson
- A Study to Assess the Effect of Abiraterone Acetate in Male Participants With Mild or Moderate Hepatic Impairment Compared to Matched Control Participants With Normal Hepatic FunctionCompletedNCT02001571Phase 1
Sponsor listed in the registry: Cougar Biotechnology, Inc. · First submitted after Cougar Biotechnology, Inc. became part of Johnson & Johnson
- An Efficacy and Safety Study of Abiraterone Acetate and Prednisone in Participants With Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based ChemotherapyCompletedNCT00485303Phase 2
Sponsor listed in the registry: Cougar Biotechnology, Inc. · First submitted before Cougar Biotechnology, Inc. became part of Johnson & Johnson
- A Pharmacokinetics Study to Assess Abiraterone Acetate Capsule and Tablet Formulations in Patients With Prostate CancerCompletedNCT00600535Phase 1
Sponsor listed in the registry: Cougar Biotechnology, Inc. · First submitted before Cougar Biotechnology, Inc. became part of Johnson & Johnson
- A Study to Determine the Effect of Food on the Pharmacokinetics of Abiraterone Acetate in Healthy Male PatientsCompletedNCT01798628Phase 1
Sponsor listed in the registry: Cougar Biotechnology, Inc. · First submitted after Cougar Biotechnology, Inc. became part of Johnson & Johnson
- A Study to Assess the Relative Bioavailability of Two Abiraterone Acetate Suspension Formulations Compared to the Abiraterone Acetate Tablet Formulation in Healthy Adult VolunteersCompletedNCT01362764Phase 1
Sponsor listed in the registry: Cougar Biotechnology, Inc. · First submitted after Cougar Biotechnology, Inc. became part of Johnson & Johnson
- A Pharmacokinetic Study of Abiraterone Acetate in Male Participants With Impaired Renal Function Compared to Individuals With Normal Renal FunctionCompletedNCT01715259Phase 1
Sponsor listed in the registry: Cougar Biotechnology, Inc. · First submitted after Cougar Biotechnology, Inc. became part of Johnson & Johnson